WESTFORD, Mass., July 19, 2024 /PRNewswire/ -- According
to SkyQuest, the global Cell Therapy Market size was
valued at USD 3.9 Billion in 2022 and
is poised to grow from USD 6.7
Billion in 2023 to USD 190.91
Billion by 2031, growing at a CAGR of 52% during the
forecast period (2024-2031).
The use of different types of cells in unique ways to treat
diseases and disorders is known as cell therapy. Advancements in
cell research and the growing acceptance of cell therapies for the
treatment of multiple chronic indications are forecasted to augment
market growth in the future. Growing demand for regenerative
medicine is also estimated to open new avenues of opportunities for
cell therapy providers in the long run. The global cell therapy
market is segmented into cell types, therapy types, therapeutic
areas, end user, and regions.
Download a detailed overview:
https://www.skyquestt.com/sample-request/cell-therapy-market
Cell Therapy Market Overview:
Report
Coverage
|
Details
|
Market Revenue in
2023
|
$ 6.7
billion
|
Estimated Value by
2031
|
$ 190.91
billion
|
Growth Rate
|
Poised to grow at a
CAGR of 52%
|
Forecast
Period
|
2024–2031
|
Forecast
Units
|
Value (USD
Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
Therapy Type,
Technology, Therapeutic Area, End User, and Region
|
Geographies
Covered
|
North America, Europe,
Asia Pacific, Middle East & Africa, Latin America
|
Report
Highlights
|
High investments in
cell therapy research and development
|
Key Market
Opportunities
|
Increasing incidence of
musculoskeletal disorders and high use of cell therapies to treat
the same
|
Key Market
Drivers
|
Growing use of cell
therapies to treat cancer indications
|
Segments covered in Cell Therapy Market are as
follows:
- Therapy Type
- Allogeneic Therapies (Stem Cell Therapies (Hematopoietic Stem
Cell Therapies, Mesenchymal Stem Cell Therapies, Others), Non-Stem
Cell Therapies (Keratinocytes & Fibroblast-based Therapies,
Others), and Autologous Therapies (Stem Cell Therapies (BM,,
Blood,, Umbilical Cord-derived Stem Cells., Adipose Derived Cells,,
Others) Non-Stem Cell Therapies (T-Cell Therapies, CAR T Cell
Therapy, T Cell Receptor (TCR)-based, Others) and Others)
- Technology
- Cell Processing, Cell Preservation, Distribution, and Handling,
Process Monitoring & Quality Control
- Therapeutic Area
- Oncology, Cardiovascular Disease (CVD), Musculoskeletal
Disorders, Dermatology, and Others
- End User
- Hospitals & Clinics, Academic & Research Institutes,
and Others
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/cell-therapy-market
High Demand for Novel Cancer Treatments to Help Oncology
Segment Maintain Prominence
Cases of cancer are increasing rapidly on a global level and
subsequently the demand for novel treatments for the same as well.
Investments in oncology research are also increasing and reaching
new heights. Cell therapies have been showing great promise in
treating multiple types of cancers. Cell therapy companies are
continually focusing on getting new approvals for their offerings
related to different cancer indications thereby helping this
segment maintain a high market share.
On the other hand, the demand for cell therapies for the
treatment of musculoskeletal disorders is estimated to surge at an
impressive pace. Rising cases of musculoskeletal tissue
degeneration and the growing demand for repair or replacement of
damaged musculoskeletal tissues will also create a new business
scope for cell therapy providers.
High Use of CAR-T Therapies Helps Autologous Therapies
Account for Dominant Share
Autologous cell therapies are preferred for their lower risk of
life-threatening complications as compared to other types of
therapies. There are also no specific requirements to match the
donor and receivers in an autologous cell therapy. A higher
possibility of treatment success and reduced risk of transplant
rejection are also key factors that help this segment hold a high
market share. CAR-T therapies are being extensively used to treat a
wide array of indications and they are classified under the
autologous segment.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/cell-therapy-market
Stem Cells are Estimated to be Used Extensively for Multiple
Cell Therapy Types
Stem cells can be guided or manipulated to perform certain
biological functions, which is why they are mostly used in cell
therapies. Growing investments in stem cell research, the high
availability of stem cells, and the proven efficacy of stem cells
in the development of novel cell therapies are all factors that
help this segment generate new opportunities for cell therapy
providers.
High demand for advanced treatments and therapeutics around the
world is forecasted to create opportunities for new as
well-established cell therapy providers.
Related Report:
3D Bioprinting Market
Cell-Based Assays Market
3D Cell Culture Market
Stem Cell Manufacturing Market
Stem Cell Therapy Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and
Accelerator of Technology and assets. We provide access to
technologies, markets and finance across sectors viz. Life
Sciences, CleanTech, AgriTech, NanoTech and Information &
Communication Technology.
We work closely with innovators, inventors, innovation seekers,
entrepreneurs, companies and investors alike in leveraging external
sources of R&D. Moreover, we help them in optimizing the
economic potential of their intellectual assets. Our experiences
with innovation management and commercialization has expanded our
reach across North America,
Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj
Singh
SkyQuest Technology
1 Apache Way,
Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/
Logo :
https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/cell-therapy-market-to-attain-a-usd-190-91-billion-valuation-in-2031--rising-investments-in-stem-cell-research-spearhead-market-expansion--skyquest-technology-302201554.html